131 related articles for article (PubMed ID: 18180298)
1. Alternate cyclin D1 mRNA splicing modulates p27KIP1 binding and cell migration.
Li Z; Wang C; Jiao X; Katiyar S; Casimiro MC; Prendergast GC; Powell MJ; Pestell RG
J Biol Chem; 2008 Mar; 283(11):7007-15. PubMed ID: 18180298
[TBL] [Abstract][Full Text] [Related]
2. PACSIN 2 represses cellular migration through direct association with cyclin D1 but not its alternate splice form cyclin D1b.
Meng H; Tian L; Zhou J; Li Z; Jiao X; Li WW; Plomann M; Xu Z; Lisanti MP; Wang C; Pestell RG
Cell Cycle; 2011 Jan; 10(1):73-81. PubMed ID: 21200149
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.
Solomon DA; Wang Y; Fox SR; Lambeck TC; Giesting S; Lan Z; Senderowicz AM; Conti CJ; Knudsen ES
J Biol Chem; 2003 Aug; 278(32):30339-47. PubMed ID: 12746453
[TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 induction of cellular migration requires p27(KIP1).
Li Z; Jiao X; Wang C; Ju X; Lu Y; Yuan L; Lisanti MP; Katiyar S; Pestell RG
Cancer Res; 2006 Oct; 66(20):9986-94. PubMed ID: 17047061
[TBL] [Abstract][Full Text] [Related]
5. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
Lu F; Gladden AB; Diehl JA
Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
[TBL] [Abstract][Full Text] [Related]
6. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
[TBL] [Abstract][Full Text] [Related]
7. Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes.
Moros A; Bustany S; Cahu J; Saborit-Villarroya I; Martínez A; Colomer D; Sola B; Roué G
Clin Cancer Res; 2014 Jan; 20(2):393-403. PubMed ID: 24178620
[TBL] [Abstract][Full Text] [Related]
8. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
[TBL] [Abstract][Full Text] [Related]
9. The Rho GTPase effector ROCK regulates cyclin A, cyclin D1, and p27Kip1 levels by distinct mechanisms.
Croft DR; Olson MF
Mol Cell Biol; 2006 Jun; 26(12):4612-27. PubMed ID: 16738326
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
11. Distinct modes of activation of phosphatidylinositol 3-kinase in response to cyclic adenosine 3', 5'-monophosphate or insulin-like growth factor I play different roles in regulation of cyclin D1 and p27Kip1 in FRTL-5 cells.
Fukushima T; Nedachi T; Akizawa H; Akahori M; Hakuno F; Takahashi S
Endocrinology; 2008 Jul; 149(7):3729-42. PubMed ID: 18403485
[TBL] [Abstract][Full Text] [Related]
12. p27Kip1 modulates cell migration through the regulation of RhoA activation.
Besson A; Gurian-West M; Schmidt A; Hall A; Roberts JM
Genes Dev; 2004 Apr; 18(8):862-76. PubMed ID: 15078817
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 regulates p27(Kip1) stability in B cells.
Bustany S; Tchakarska G; Sola B
Cell Signal; 2011 Jan; 23(1):171-9. PubMed ID: 20837141
[TBL] [Abstract][Full Text] [Related]
15. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
16. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
Mann DJ; Higgins T; Jones NC; Rozengurt E
Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine inhibits deregulated cell cycle in pancreatic cancer cells: Differential regulation of p21
Singh K; Dong Q; TimiriShanmugam PS; Koul S; Koul HK
Cancer Lett; 2018 Jul; 425():164-173. PubMed ID: 29605511
[TBL] [Abstract][Full Text] [Related]
18. Identification of the cyclin D1b mRNA variant in mouse.
Wu J; Wu SH; Bollig A; Thakur A; Liao DJ
Mol Biol Rep; 2009 May; 36(5):953-7. PubMed ID: 18446443
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.
Comstock CE; Augello MA; Benito RP; Karch J; Tran TH; Utama FE; Tindall EA; Wang Y; Burd CJ; Groh EM; Hoang HN; Giles GG; Severi G; Hayes VM; Henderson BE; Le Marchand L; Kolonel LN; Haiman CA; Baffa R; Gomella LG; Knudsen ES; Rui H; Henshall SM; Sutherland RL; Knudsen KE
Clin Cancer Res; 2009 Sep; 15(17):5338-49. PubMed ID: 19706803
[TBL] [Abstract][Full Text] [Related]
20. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
